| Literature DB >> 32213551 |
Garry Alan Tew1,2, Robin Bedford3, Esther Carr4, James William Durrand5,6, Joanne Gray7, Rhiannon Hackett4, Scott Lloyd3,8, Sarah Peacock4, Sarah Taylor4, David Yates9, Gerard Danjoux4.
Abstract
Optimising health and well-being before elective major surgery via prehabilitation initiatives is important for good postoperative outcomes. In a busy tertiary centre in North East England, the lack of a formal prehabilitation service meant that opportunities were being missed to optimise patients for surgery. This quality improvement project aimed to implement and evaluate a community-based prehabilitation service for people awaiting elective major surgery: PREP-WELL. A multidisciplinary, cross-sector team introduced PREP-WELL in January 2018. PREP-WELL provided comprehensive assessment and management of perioperative risk factors in the weeks before surgery. During a 12-month pilot, patients were referred from five surgical specialties at James Cook University Hospital. Data were collected on participant characteristics, behavioural and health outcomes, intervention acceptability and costs, and process-related factors. By December 2018, 159 referrals had been received, with 75 patients (47%) agreeing to participate. Most participants opted for a supervised programme (72%) and were awaiting vascular (43%) or orthopaedic (35%) surgery. Median programme duration was 8 weeks. The service was delivered as intended with participants providing positive feedback. Health-related quality of life (HRQoL; EuroQol 5D (EQ-5D) utility) and functional capacity (6 min walk distance) increased on average from service entry to exit, with mean (95% CI) changes of 0.108 (-0.023 to 0.240) and 35 m (-5 to 76 m), respectively. Further increases in EQ5D utility were observed at 3 months post surgery. Substantially more participants were achieving recommended physical activity levels at exit and 3 months post surgery compared with at entry. The mean cost of the intervention was £405 per patient; £52 per week. The service was successfully implemented within existing preoperative pathways. Most participants were very satisfied and improved their risk profile preoperatively. Funding has been obtained to support service development and expansion for at least 2 more years. During this period, alternative pathways will be developed to facilitate wider access and greater uptake. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: health behaviour; healthcare quality improvement; preoperative care; rehabilitation
Mesh:
Year: 2020 PMID: 32213551 PMCID: PMC7206908 DOI: 10.1136/bmjoq-2019-000898
Source DB: PubMed Journal: BMJ Open Qual ISSN: 2399-6641
Summary of prehabilitation interventions and what was offered to participants attending supervised sessions
| Perioperative risk factor | Summary of intervention | Summary of what was offered to participants attending supervised sessions (n=54) |
| Physical inactivity/low physical fitness | Supervised aerobic and resistance exercise training (one or two sessions per week) and unsupervised exercise and physical activity (as agreed with intervention facilitator). Patients with an increased risk of postoperative pulmonary complications also do inspiratory muscle training. See | All 54 participants had exercise as an agreed intervention; 17 (31%) also undertook inspiratory muscle training |
| Smoking | Brief advice on smoking cessation from project manager with onward referral to stop smoking services providing combined structured counselling and nicotine replacement therapy. | Seven participants were smokers at baseline |
| Underweight | Fortisip Compact Protein high energy (2.4 kcal/mL), high protein (18 g/bottle) nutritional supplement; 2×125 mL bottle each day (2.4 kcal/mL) | Two underweight participants received nutritional supplements |
| Obese | Brief advice on diet from project manager emphasising healthy eating with onward referral to local specialist weight management service. | Three participants with obesity received brief advice from the project manager; one was referred to the weight management service |
| Frailty | Notification of general practitioner (GP) and secondary care teams by project manager | One participant was frail at baseline—their GP and secondary care teams were notified |
| Excessive alcohol | Brief advice on alcohol reduction from project manager to reduce intake below 14 units weekly. Onward referral to specialist alcohol services if features of dependence present. | 25 (46%) participants were alcohol drinkers at baseline |
| Anaemia | Rapid access to preoperative anaemia pathway (with provision of intravenous iron), or referral for management via GP dependent on severity and preoperative timeframes. | Seven participants were anaemic at baseline |
| Obstructive sleep apnoea | Expedited home-based diagnostic sleep test to identify obstructive sleep apnoea following identification of increased risk via initial questionnaire screening | Three participants were deemed high risk for obstructive sleep apnoea; following further evaluation, one initiated continuous positive airway pressure therapy |
| Anxiety/depression | Referral for mindfulness training or psychological counselling | Nine participants had elevated anxiety |
HADS, Hospital Anxiety and Depression Scale.
Participant characteristics at service entry
| Supervised programme (n=54) | Supervised programme and completed exit assessment (n=27) | Home-based programme (n=21) | |
| Age, years | 69 (10) | 67 (12) | 68 (8) |
| Range | 42–87 | 42–84 | 51–82 |
| Male sex, n (%) | 38 (70) | 21 (78) | 14 (67) |
| Ethnicity, n (%) | |||
| White British | 53 (98) | 27 (100) | 21(100) |
| Asian | 1 (2) | 0 (0) | 0 (0) |
| Marital status, n (%) | |||
| Married | 33 (61) | 13 (48) | 14 (66) |
| Other* | 21 (39) | 14 (52) | 7 (33) |
| Body mass index, kg/m2 | 29.4 (5.3) | 30.3 (5.2) | 28.5 (3.8) |
| >35, n (%) | 4 (7) | 4 (15) | 1 (5) |
| <20, n (%) | 2 (4) | 1 (4) | 0 (0) |
| Comorbidities, n (%) | |||
| Ischaemic heart disease | 10 (19) | 5 (19) | 3 (14) |
| Angina | 5 (9) | 3 (11) | 0 (0) |
| Heart failure | 2 (4) | 0 (0) | 0 (0) |
| Hypertension | 35 (65) | 17 (63) | 10 (48) |
| Arrhythmia | 8 (15) | 4 (15) | 4 (19) |
| Chronic obstructive pulmonary disease | 7 (13) | 2 (7) | 1 (5) |
| Asthma | 11 (20) | 4 (15) | 2 (10) |
| Arthritis | 34 (63) | 17 (63) | 11 (52) |
| Diabetes | 14 (26) | 5 (19) | 2 (10) |
| Active malignancy | 8 (15) | 3 (11) | 1 (5) |
| Anaemia | 13 (24) | 4 (15) | 2 (10) |
| Frailty† | 2 (4) | 0 (0) | 1 (5) |
| Obstructive sleep apnoea | 2 (4) | 1 (4) | 0 (0) |
| Cognitive impairment‡ | 20 (37) | 10 (37) | 7 (33) |
| Surgical specialty, n (%) | |||
| Vascular | 23 (43) | 12 (44) | 9 (43) |
| Orthopaedics | 20 (37) | 10 (37) | 6 (29) |
| Upper gastrointestinal | 6 (11) | 3 (11) | 2 (10) |
| Urology | 4 (7) | 1 (4) | 2 (10) |
| Colorectal | 1 (2) | 1 (4) | 2 (10) |
| Physically active§, n (%) | |||
| Aerobic | 6 (11) | 4 (15) | 4 (19) |
| Muscle strengthening | 2 (4) | 0 (0) | 3 (14) |
| Aerobic and muscle | 0 (0) | 0 (0) | 0 (0) |
| Smoking status, n (%) | |||
| Current | 8 (15) | 4 (15) | 0 (0) |
| Previous | 15 (28) | 8 (30) | 5 (23) |
| Never | 31 (57) | 15 (56) | 16 (77) |
| Alcohol consumption, n (%) | |||
| 0 units/week | 29 (54) | 12 (44) | 8 (38) |
| 0–14 units/week | 14 (26) | 10 (37) | 8 (38) |
| >14 units/week | 11 (20) | 5 (19) | 5 (24) |
Data are presented as mean (SD) unless otherwise stated.
*Includes single, widowed, divorced and cohabiting.
†Defined as a Clinical Frailty Scale score of ≥5.
‡Defined as a mini-cog score of ≤4.
§Defined as meeting WHO guidelines for physical activity.30
Risk factor, functional capacity, EuroQol 5D (EQ-5D) and Hospital Anxiety and Depression Scale (HADS) data for participants attending supervised sessions who completed all available assessments
| N | Service entry | Service exit presurgery | 3 months post surgery | Entry to exit | Exit to postsurgery follow-up | |
| Non-smokers, n (%) | 24 | 20 (83) | 21 (87.5) | 20 (83) | N/A | N/A |
| Alcohol consumption, n (%) | ||||||
| 0 units/week | 23 | 10 (43) | 15 (65) | 13 (57) | N/A | N/A |
| ≤14 units/week | 19 (83) | 20 (87) | 22 (96) | N/A | N/A | |
| Physically active* | ||||||
| Aerobic, n (%) | 24 | 4 (17) | 18 (75) | 15 (62.5) | N/A | N/A |
| Muscle strengthening, n (%) | 0 (0) | 21 (87.5) | 7 (29) | N/A | N/A | |
| Aerobic and muscle, n (%) | 0 (0) | 18 (75) | 7 (29) | N/A | N/A | |
| Body mass index (kg/m2) | 24 | 30.3 (5.2) | 30.0 (5.2) | N/A | −0.3 (−0.8 to 0.2) | N/A |
| Range 20–35, n (%) | 20 (83) | 21 (87.5) | N/A | N/A | N/A | |
| Systolic blood pressure (mm Hg) | 20 | 147 (18) | 142 (17) | N/A | −6 (−12 to 0) | N/A |
| Diastolic blood pressure (mm Hg) | 20 | 87 (8) | 83 (7) | N/A | −4 (−8 to 0) | N/A |
| 6 min walk distance (m) | 18 | 444 (177) | 479 (155) | N/A | 35 (−5 to 76) | N/A |
| EQ-5D utility index† | 25 | 0.535 (0.375) | 0.643 (0.338) | 0.778 (0.299) | 0.108 (−0.023 to 0.240) | 0.244 (0.049 to 0.438) |
| EQ-VAS‡ | 25 | 68 (16) | 68 (17) | 76 (19) | 0 (−4 to 5) | 8 (1 to 16) |
| HADS-A§ | 33 | |||||
| Score, mean (SD) | 5.5 (4.8) | 5.4 (5.1) | 4.4 (5.0) | −0.1 (−1.8 to 1.5) | −1.0 (−2.3 to 0.2) | |
| Any anxiety symptoms (score 8‒21), n (%) | 10 (30) | 8 (24) | 9 (27) | N/A | N/A | |
| Anxiety (score 11‒21), n (%) | 6 (18) | 5 (15) | 6 (18) | N/A | N/A | |
| HADS-D§ | 33 | |||||
| Score, mean (SD) | 4.6 (4.3) | 3.8 (3.9) | 2.5 (3.7) | −0.8 (−1.9 to 0.3) | −1.3 (−2.1 to −0.5) | |
| Any depressive symptoms (score 8‒21), n (%) | 6 (18) | 2 (6) | 1 (3) | N/A | N/A | |
| Depression (score 11‒21), n (%) | 3 (9) | 1 (3) | 1 (3) | N/A | N/A | |
Data are presented as mean (SD) or mean (95% CI).
*Defined as meeting WHO guidelines for physical activity.30
†EQ-5D utility scores range from −0.594 to 1, with higher scores indicating a better health status.
‡EuroQol Visual Analogue Scale (EQ-VAS) scores range from 0 to 100, with higher scores indicating a better health status.
§Hospital Anxiety and Depression Scale—Anxiety Subscale Score (HADS-A) and Hospital Anxiety and Depression Scale—Depression Subscale Score (HADS-D) range from 0 to 21, with higher scores indicating more severe symptoms.
N/A, not applicable.